glp-1 receptor agonists and sglt2 inhibitors SGLT-2 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease Effects of Pharmacologic Therapy for

Understanding their distinct mechanisms, clinical evidence bases, and how genetic and biomarker data inform personalized treatment selection helps patients and providers make evidence-based decisions

The best results happen when the medicine is used along with healthy eating and exercise, and people may gain weight back if they stop taking the medicine

Retatrutide, a new weight-loss drug, helped people lose 30% of their body weight in a study, rivaling results seen with weight-loss surgery.

In crude analyses, GLP-1 receptor agonist use was associated with an increased incidence of suicidality compared with DPP-4 inhibitors (crude incidence rates 3.9 v 1.8 per 1000 person years, respectively

This review examines their expanding role, evaluating efficacy compared to alternative treatments, ...